Interviewed by: Ashley Krull, Ph.D. Telegraft Contributing Editor Mayo Clinic Rochester Rochester, United States Featured Member: Jennifer Hollands Government and Academic Liaison Cell Therapies Peter MacCallum Cancer Centre Melbourne, Victoria, Australia Dr. Jennifer Hollands...
1 Comment - no search term matches found in comments.
by Gaurav Sutrave, B Sc(Med), MBBS, PhD Staff Specialist Haematologist Westmead Hospital Sydney, Australia The clinical success of CD19 specific chimeric antigen receptor (CAR) T cells and subsequent regulatory approvals for their use in the treatment of relapsed and refractory B cell...
By:Ashley Krull, Ph.D. Telegraft Contributing Editor Mayo Clinic Rochester Rochester, United States Featured Member: Bernd Giebel, Ph.D. Institute for Transfusion Medicine University Hospital Essen University of Duisburg-Essen Essen, Germany Article Dr. Bernd Giebel directs a...
Meet the Investor Brought to you by the ISCT Business Development & Finance Committee Bryan Poltilove Operating Partner BroadOak Capital Partners As Operating Partner with BroadOak, Mr. Poltilove leads the firm’s investments in Cell and Gene...
by Miguel Forte, M.D., Ph.D. and Bruce Levine, Ph.D. The field of C> is experiencing great growth, and we are witnessing a growing number of products being approved. The hope would be that these products following regulatory approvals and marketing efforts will be reaching patients...
Member Spotlight: Qasim Rafiq, MEng, PhD, CEng, CSci Engineering the Future of CGT Research and Training By:Ashley Krull, PhD Telegraft Contributing Editor Mayo Clinic Rochester Rochester, United States Dr. Ashley Krull, of the Telegraft Hub Editorial Board sits down...
TED/TEDx Talks, Another Great Way to Communicate Science by: Joaquim Vives, PhD Editorial Board Member Banc de Sang i Teixits Barcelona, Spain I did it! I gave a TEDx Talk . WATCH HERE TEDxUABarcelona was a space for disseminating talent...
Dr. Ashley Krull, of the Telegraft Hub Editorial Board sits down with Sven Kili, Co-chair of ISCT 2022. Dr. Sven Kili is the CEO of the Swiss-based biotechnology company Antion Biosciences. In addition to his background in surgery and biotherapeutics, Dr. Kili serves on numerous boards and...
Dr. Ashley Krull, of the Telegraft Hub Editorial Board sits down with Bambi Grilley, Co-chair of ISCT 2022. Bambi Grilley is the Director of Clinical Research and Early Product Development within the Center for Cell and Gene Therapy at Baylor College of Medicine. In addition to her breadth...